The ‘broken’ antimicrobial market: A ‘looming cloud’ over medicine
06 January 2020
According to a recent estimate, at least 153,000 people may die annually in the United States from drug-resistant infections, which would make it the third-leading cause of death in the country. Worsening resistance profiles worldwide may lead to an era where all antibiotics fall short and patients cannot be cured, experts have warned.
Further reading: Infectious Disease News
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
